 Geneva, Switzerland and Boston, MA November 13, 2020 ObsEva SA NASDAQ: OBSV SIX: OBSN, a clinical-stage biopharmaceutical company developing and commercializing novel therapies to improve womens reproductive health today announced that Company Management will present an update on the Company and its pipeline at the 11th Annual Jefferies Virtual London Healthcare Conference, taking place November 17 - 19, 2020. 